Related Experiment Video
Updated: Jul 4, 2025

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
Published on: September 18, 2020
Tumor-derived Prevotella intermedia aggravates gastric cancer by enhancing Perilipin 3 expression
Wei Liang1,2, Zhengyang Zhou3, Qizhao Gao1
1Department of Clinical Laboratory, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.
Abstract:
The indigenous microbial milieu within tumorous tissues exerts a pivotal influence on the genesis and advancement of gastric cancer (GC). This investigation scrutinizes the functions and molecular mechanisms attributed to Prevotella intermedia in the malignant evolution of GC. Isolation of P. intermedia from paired GC tissues was undertaken. Quantification of P. intermedia abundance in 102 tissues was accomplished using quantitative real-time PCR (qRT-PCR). Assessment of the biological effects of P. intermedia on GC cells was observed using culture medium supernatant. Furthermore, the protein profile of GC cells treated with tumor-derived P. intermedia was examined through label-free protein analysis. The functionality of perilipin 3 (PLIN3) was subsequently confirmed using shRNA. Our investigation revealed that the relative abundance of P. intermedia in tumor tissues significantly surpassed that of corresponding healthy tissues. The abundance of P. intermedia exhibited correlations with tumor differentiation (p = 0.006), perineural invasion (p = 0.004), omentum majus invasion (p = 0.040), and the survival duration of GC patients (p = 0.042). The supernatant derived from tumor-associated P. intermedia bolstered the proliferation, clone formation, migration, and invasion of GC cells. After indirect co-cultivation with tumor-derived P. intermedia, dysregulation of 34 proteins, including PLIN3, was discerned in GC cells. Knockdown of PLIN3 mitigated the malignancy instigated by P. intermedia in GC cells. Our findings posit that P. intermedia from the tumor microenvironment plays a substantial role in the malignant progression of GC via the modulation of PLIN3 expression. Moreover, the relative abundance of P. intermedia might serve as a potential biomarker for the diagnosis and prognosis of GC.
Insights
Prevotella intermedia bacteria in gastric cancer (GC) tissues promote tumor growth and invasion. This bacterium influences GC progression by altering perilipin 3 (PLIN3) expression, suggesting it could be a diagnostic and prognostic biomarker.
Area of Science:
- Microbiology
- Oncology
- Molecular Biology
Background:
- The tumor microenvironment, including indigenous microbes, significantly impacts gastric cancer (GC) development.
- Prevotella intermedia (P. intermedia) is implicated in GC pathogenesis, but its precise roles and mechanisms require elucidation.
Purpose of the Study:
- To investigate the functional roles and molecular mechanisms of P. intermedia in the malignant progression of GC.
- To assess the potential of P. intermedia abundance as a biomarker for GC diagnosis and prognosis.
Main Methods:
- Isolation and quantification of P. intermedia from GC tissues using quantitative real-time PCR (qRT-PCR).
- Assessing the effects of P. intermedia supernatant on GC cell proliferation, migration, and invasion.
- Analyzing protein expression changes in GC cells co-cultured with P. intermedia via label-free proteomics.
- Investigating the role of perilipin 3 (PLIN3) using shRNA knockdown.
Main Results:
- P. intermedia was significantly more abundant in GC tumor tissues than in healthy tissues.
- Increased P. intermedia abundance correlated with poorer tumor differentiation, invasion, and reduced patient survival.
- P. intermedia supernatant enhanced GC cell proliferation, migration, and invasion.
- P. intermedia altered the expression of 34 proteins in GC cells, including PLIN3, and PLIN3 knockdown reversed P. intermedia-induced malignancy.
Conclusions:
- P. intermedia promotes GC malignant progression through PLIN3 modulation within the tumor microenvironment.
- P. intermedia abundance may serve as a potential biomarker for GC diagnosis and prognosis.

